InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
-0.64%
)
Bitcoin
56,697.78
(
-0.50%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5392
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: dmlabuda post# 11990

Sunday, 02/19/2012 6:17:38 PM

Sunday, February 19, 2012 6:17:38 PM

Post# of 26138
This is probably true with most industries but less so in the biotech industry. In the biotech industry they also rise on their potential for future revenue. I counted 38 companies trading above Biosantes' market cap all with less annual revenue than Biosante.
One being Pharmasset with a market cap of $10.36 Billion which was bought by Gilead.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up